Fresenius to Settle Dialysis Claims for $250M

Drug Industry Daily
A A
Fresenius Medical Care will shell out $250 million to settle more than 400 lawsuits alleging harm from two of its drugs, GranuFlo and NaturaLyte, under a proposed settlement announced Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily